Table 2.
Pathological Findings of lesions.
| Pathology Result | Number of Lesions (%) |
|---|---|
| Benign | 72 (61.5%) |
| Adenosis | 34 (29.1%) |
| Fibroadenoma | 24 (20.5%) |
| Intraductal papilloma | 7 (6.0%) |
| Chronic mammary inflammation | 3 (2.6%) |
| Ductal epithelial hyperplasia | 3 (2.6%) |
| Adeno-myoepithelioma | 1 (0.8%) |
| Malignant | 45 (38.5%) |
| Ductal carcinoma in situ | 9 (7.7%) |
| Invasive ductal carcinoma grade 1 | 6 (5.1%) |
| Invasive ductal carcinoma grade 2 | 12 (10.3%) |
| Invasive ductal carcinoma grade 3 | 8 (6.8%) |
| Invasive lobular carcinoma grade 1 | 3 (2.6%) |
| Invasive lobular carcinoma grade 2 | 3 (2.6%) |
| Invasive lobular carcinoma grade 3 | 2 (1.7%) |
| Neuroendocrine carcinoma | 2 (1.7%) |
Data are presented as numbers (percentages).